Sales of dermatologicals continued to increase in 2019, thanks to the growing levels of self-medication. There were advertising and promotional campaigns running in the 2017-2019 period for topical and even vaginal antifungals, benefiting sales of both OTC and Rx products, with the main emphasis being on the treatment of bacterial issues rather than fungi.
One of the main growth drivers is the switch towards more natural products at the expense of dermatologicals with potentially noxious ingredients – for instance corticoid-based creams. In nappy (diaper) rash treatments and paediatric dermatologicals, this can be seen in the recent “liniment” trend, with oleo-limestone liniment a popular choice.
The most dynamic products in 2019 were haemorrhoid treatments and antipruritics. Haemorrhoid treatments performed well on the back of a growing level of self-medication, with Johnson & Johnson’s Titanoréïne line the dominant brand in this category.
Johnson & Johnson Santé Beauté France continued to lead what is an extremely fragmented competitive landscape in dermatologicals, followed by Laboratoires Pierre Fabre. Both players cover many types of dermatologicals with a large number of brands and products.
Antiparasitics/lice (head and body) treatments is led by Coopération Pharmaceutique Française SAS (Cooper) with its Pouxit brand, followed by Omega Pharma with Paranix and Merck Médication Familiale with its Poux Apaisyl range. However, there is not only strong competition between these players, but also with other companies operating in the category.
Good performances in topical germicidals/antiseptics can be attributed to OTC repurchases of Rx products and advertising of OTC products. Bayer’s Biseptine recorded growth in 2019 thanks to OTC repurchases in the summer by consumers who had previously used the product on reimbursed prescription.
You have no recently viewed reports.
Why not browse through our Featured or Trending Reports to see what we have to offer?
Discover the latest market trends and uncover sources of future market growth for the Medicated Skin Care industry in France with research from Euromonitor's team of in-country analysts.
Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.
If you're in the Medicated Skin Care industry in France, our research will save you time and money while empowering you to make informed, profitable decisions.
The Medicated Skin Care in France market research report includes:
Our market research reports answer questions such as:
Why buy this report?
This industry report originates from Passport, our Consumer Health market research database.